BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report)’s stock price was down 11.4% during mid-day trading on Thursday . The company traded as low as $0.12 and last traded at $0.15. Approximately 196,944 shares changed hands during trading, an increase of 77% from the average daily volume of 111,154 shares. The stock had previously closed at $0.17.
BriaCell Therapeutics Price Performance
The firm’s fifty day moving average is $0.31 and its two-hundred day moving average is $0.27.
About BriaCell Therapeutics
BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.
Featured Articles
- Five stocks we like better than BriaCell Therapeutics
- How to Invest in the Best Canadian Stocks
- Top ETFs That Beat the Market in 2024 and Could Do It Again
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- J.B. Hunt Leads Truckers Lower: Buy Them While They’re Down?
- How to Start Investing in Real Estate
- MarketBeat Week in Review – 01/13 – 01/17
Receive News & Ratings for BriaCell Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BriaCell Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
